Latest news with #ELABS
Yahoo
14-05-2025
- Automotive
- Yahoo
European Growth Leaders With Insider Influence May 2025
As European markets navigate a period of mixed performance, with the STOXX Europe 600 Index rising for the fourth consecutive week amid easing trade tensions, investors are increasingly focused on companies that demonstrate robust growth potential and strong insider ownership. In this context, stocks with high levels of insider influence can offer unique insights into company strategies and align management's interests closely with those of shareholders, making them appealing options in today's uncertain economic landscape. Name Insider Ownership Earnings Growth Yubico (OM:YUBICO) 36.5% 27% Pharma Mar (BME:PHM) 11.8% 43.1% KebNi (OM:KEBNI B) 38.4% 66.1% Vow (OB:VOW) 13.1% 81% Bergen Carbon Solutions (OB:BCS) 12% 52.2% Elicera Therapeutics (OM:ELIC) 23.8% 97.2% CD Projekt (WSE:CDR) 29.7% 37.4% Elliptic Laboratories (OB:ELABS) 22.6% 51.9% Lokotech Group (OB:LOKO) 13.6% 58.1% Nordic Halibut (OB:NOHAL) 29.7% 60.7% Click here to see the full list of 209 stocks from our Fast Growing European Companies With High Insider Ownership screener. We'll examine a selection from our screener results. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Ferrari N.V. designs, engineers, produces, and sells luxury performance sports cars globally and has a market cap of €78.52 billion. Operations: Ferrari's revenue primarily comes from its luxury performance sports car segment, generating €6.88 billion. Insider Ownership: 10.6% Ferrari's earnings are projected to grow at 7.95% annually, outpacing the Italian market, and its Return on Equity is expected to remain strong. Despite recent insider selling, Ferrari has engaged in significant share buybacks, enhancing shareholder value. The company reported robust first-quarter results with sales of €1.79 billion and net income of €411.64 million. Additionally, Ferrari confirmed full-year revenue guidance exceeding €7 billion while managing potential profitability impacts due to new U.S.-EU import tariffs. Navigate through the intricacies of Ferrari with our comprehensive analyst estimates report here. Insights from our recent valuation report point to the potential overvaluation of Ferrari shares in the market. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Mowi ASA is a seafood company that produces and sells Atlantic salmon products globally, with a market cap of NOK97.84 billion. Operations: Mowi ASA generates revenue through several segments, including Feed (€1.12 billion), Farming (€3.51 billion), Sales & Marketing - Markets (€4.00 billion), and Sales & Marketing - Consumer Products (€3.70 billion). Insider Ownership: 14.7% Mowi's earnings are forecast to grow significantly at 20.1% annually, surpassing the Norwegian market average. Despite high debt levels and a low Return on Equity projection of 18.6%, Mowi trades at a substantial discount to its estimated fair value. Recent strategic reviews of their Feed division could streamline operations further, while new product launches like the Norwegian Salmon Fjord Burgers in the US may enhance revenue growth beyond the current 6.5% annual forecast. Click to explore a detailed breakdown of our findings in Mowi's earnings growth report. Our comprehensive valuation report raises the possibility that Mowi is priced lower than what may be justified by its financials. Simply Wall St Growth Rating: ★★★★★☆ Overview: EQT AB (publ) is a global private equity and venture capital firm focusing on private capital and real asset segments, with a market cap of approximately SEK351.48 billion. Operations: The company's revenue is derived from its Private Capital segment at €1.36 billion and Real Assets segment at €951.90 million, with an additional contribution of €41.50 million from the Central segment. Insider Ownership: 12.6% EQT's earnings are projected to grow significantly at 24.9% annually, outpacing the Swedish market. The company, trading slightly below its estimated fair value, has seen substantial insider buying recently. With a high forecasted Return on Equity of 21.4%, EQT is exploring strategic partnerships, such as a potential tie-up with Arctos Partners LP. Additionally, the recent $500 million debt offering supports ongoing initiatives and expansion plans under new CEO Per Franzén's leadership. Take a closer look at EQT's potential here in our earnings growth report. In light of our recent valuation report, it seems possible that EQT is trading beyond its estimated value. Take a closer look at our Fast Growing European Companies With High Insider Ownership list of 209 companies by clicking here. Ready For A Different Approach? Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 23 best rare earth metal stocks of the very few that mine this essential strategic resource. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include BIT:RACE OB:MOWI and OM:EQT. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
28-03-2025
- Business
- Yahoo
European Growth Stocks Insiders Are Betting On
As European markets show signs of recovery, with the STOXX Europe 600 Index snapping a two-week losing streak, investors are keeping a close watch on growth stocks that insiders are heavily investing in. In an environment where government spending hopes and trade tensions shape economic forecasts, companies with high insider ownership can signal confidence from those closest to their operations. Name Insider Ownership Earnings Growth Elicera Therapeutics (OM:ELIC) 27.8% 97.2% Pharma Mar (BME:PHM) 11.8% 40.8% Vow (OB:VOW) 13.1% 111.2% Bergen Carbon Solutions (OB:BCS) 12% 50.8% Truecaller (OM:TRUE B) 29.7% 24.7% Elliptic Laboratories (OB:ELABS) 22.6% 88.2% CD Projekt (WSE:CDR) 29.7% 36.8% Ortoma (OM:ORT B) 27.7% 68.6% Nordic Halibut (OB:NOHAL) 29.8% 56.3% Circus (XTRA:CA1) 26% 51.4% Click here to see the full list of 238 stocks from our Fast Growing European Companies With High Insider Ownership screener. Let's review some notable picks from our screened stocks. Simply Wall St Growth Rating: ★★★★★☆ Overview: Stadler Rail AG, with a market cap of CHF2.15 billion, is involved in the manufacture and sale of trains across Switzerland, Germany, Austria, Western and Eastern Europe, the Americas, CIS countries, and internationally through its subsidiaries. Operations: Stadler Rail's revenue is primarily derived from its Rolling Stock segment at CHF2.74 billion, followed by Service & Components at CHF866.43 million, and Signalling at CHF109.11 million. Insider Ownership: 14.5% Earnings Growth Forecast: 46.1% p.a. Stadler Rail, with significant insider ownership, faces challenges as recent earnings show a decline in net income to CHF 38.42 million from CHF 124.32 million year-on-year, and profit margins have decreased to 1.2%. Despite this, the company is poised for substantial growth, with earnings expected to rise significantly at an annual rate of 46.1%, outpacing the Swiss market's average growth forecast of 11.1%. Get an in-depth perspective on Stadler Rail's performance by reading our analyst estimates report here. Our comprehensive valuation report raises the possibility that Stadler Rail is priced higher than what may be justified by its financials. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Fielmann Group AG operates in the optical and hearing aid sectors across Germany, Switzerland, Austria, and internationally with a market cap of €3.62 billion. Operations: The company generates revenue of €2.16 billion from its medical-optical supplies segment. Insider Ownership: 17.9% Earnings Growth Forecast: 20.6% p.a. Fielmann Group, with substantial insider ownership, is positioned for growth as its earnings are forecast to increase significantly by 20.6% annually over the next three years, surpassing the German market's average. Despite trading at a discount of 45.3% below fair value estimates and an unstable dividend history, analysts agree on a potential stock price rise of 29.4%. Recent management changes include Peter Lothes joining the board as a member, effective March 2025. Click here and access our complete growth analysis report to understand the dynamics of Fielmann Group. According our valuation report, there's an indication that Fielmann Group's share price might be on the cheaper side. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Redcare Pharmacy NV operates as an online pharmacy across several European countries, including the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France with a market cap of €2.53 billion. Operations: The company generates revenue through its DACH segment with earnings of €1.93 billion and its International segment with earnings of €436.50 million. Insider Ownership: 11.7% Earnings Growth Forecast: 47.8% p.a. Redcare Pharmacy shows promising growth potential, with insiders actively buying shares recently. The company trades at a substantial discount of 58.6% below its estimated fair value, and revenue is expected to grow by 15.9% annually, outpacing the German market's average growth rate. Despite current losses, Redcare anticipates becoming profitable within three years and projects over 25% sales growth for 2025. Recent legal victories support its business model of offering bonuses on prescription orders. Unlock comprehensive insights into our analysis of Redcare Pharmacy stock in this growth report. The valuation report we've compiled suggests that Redcare Pharmacy's current price could be inflated. Get an in-depth perspective on all 238 Fast Growing European Companies With High Insider Ownership by using our screener here. Curious About Other Options? We've found 20 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include SWX:SRAIL XTRA:FIE and XTRA:RDC. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
28-03-2025
- Business
- Yahoo
European Growth Stocks With High Insider Ownership March 2025
In March 2025, the European markets have shown resilience, with the STOXX Europe 600 Index ending higher after two weeks of losses, driven by optimism around potential government spending despite ongoing concerns about U.S. tariffs. As central banks navigate a complex landscape of growth and inflation challenges, investors are increasingly focusing on companies with strong fundamentals and high insider ownership as indicators of confidence in long-term growth potential. Name Insider Ownership Earnings Growth Elicera Therapeutics (OM:ELIC) 27.8% 97.2% Pharma Mar (BME:PHM) 11.8% 40.8% Vow (OB:VOW) 13.1% 111.2% Bergen Carbon Solutions (OB:BCS) 12% 50.8% Truecaller (OM:TRUE B) 29.7% 24.7% Elliptic Laboratories (OB:ELABS) 22.6% 88.2% CD Projekt (WSE:CDR) 29.7% 36.8% Ortoma (OM:ORT B) 27.7% 68.6% Nordic Halibut (OB:NOHAL) 29.8% 56.3% Circus (XTRA:CA1) 26% 51.4% Click here to see the full list of 238 stocks from our Fast Growing European Companies With High Insider Ownership screener. Let's explore several standout options from the results in the screener. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Lectra SA offers industrial intelligence solutions for the fashion, automotive, furniture markets, and other industries globally, with a market cap of €1.04 billion. Operations: The company's revenue segments are divided as follows: €176.10 million from the Americas, €131.53 million from Asia-Pacific, and €219.05 million from EMEA (Europe, Middle East and Africa). Insider Ownership: 17.7% Lectra, with significant insider ownership, is poised for growth despite recent executive changes. The company expects earnings to grow significantly at 23.1% annually, outpacing the French market's 13%. While revenue growth is moderate at 6% annually, it surpasses the market average of 5.9%. Analysts predict a potential stock price increase of 22.6%, and Lectra trades below its estimated fair value by 26.4%. Recent financials show stable performance with sales reaching €526.67 million in 2024. Delve into the full analysis future growth report here for a deeper understanding of Lectra. In light of our recent valuation report, it seems possible that Lectra is trading behind its estimated value. Simply Wall St Growth Rating: ★★★★★★ Overview: MedinCell S.A. is a pharmaceutical company based in France that develops long-acting injectables across various therapeutic areas, with a market cap of €489.29 million. Operations: The company's revenue is primarily derived from its pharmaceuticals segment, totaling €13.20 million. Insider Ownership: 13.9% MedinCell, with substantial insider ownership, is positioned for significant growth. Analysts forecast revenue to grow at 68.4% annually, far exceeding the French market average of 5.9%, and earnings are expected to increase by 115.25% per year. The company trades at a considerable discount to its estimated fair value and anticipates becoming profitable within three years. Recent strategic board appointments and collaborations with Teva Pharmaceuticals enhance its growth prospects in the biopharmaceutical sector. Click to explore a detailed breakdown of our findings in MedinCell's earnings growth report. Our expertly prepared valuation report MedinCell implies its share price may be lower than expected. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Ratos AB (publ) is a private equity firm focused on buyouts, turnarounds, add-on acquisitions, and middle market transactions, with a market cap of SEK11.17 billion. Operations: The company's revenue segments include Consumer at SEK5.34 billion, Construction at SEK12.07 billion, Product Solutions at SEK5.10 billion, Industrial Services at SEK5.36 billion, and Critical Infrastructure at SEK4.31 billion. Insider Ownership: 13.2% Ratos, with significant insider ownership, is poised for robust earnings growth, forecasted at 36% annually, outpacing the Swedish market's 9.1%. Despite a recent net loss and lower profit margins compared to last year, it trades below its estimated fair value. Revenue growth is modest at 3.1% annually but exceeds the market average. Recent leadership changes include appointing Katarina Ageborg as Chairman, potentially strengthening strategic direction given her extensive experience in life sciences. Click here to discover the nuances of Ratos with our detailed analytical future growth report. Our comprehensive valuation report raises the possibility that Ratos is priced higher than what may be justified by its financials. Click this link to deep-dive into the 238 companies within our Fast Growing European Companies With High Insider Ownership screener. Contemplating Other Strategies? We've found 20 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include ENXTPA:LSS ENXTPA:MEDCL and OM:RATO B. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
03-03-2025
- Business
- Yahoo
European Growth Stocks With High Insider Ownership In March 2025
As European markets continue to show resilience, with the STOXX Europe 600 Index marking its longest streak of weekly gains since 2012, investors are increasingly looking towards growth stocks with substantial insider ownership as potential opportunities. In this context, companies where insiders hold significant stakes may offer a unique alignment of interests and stability amidst broader economic uncertainties. Name Insider Ownership Earnings Growth TF Bank (OM:TFBANK) 15.6% 20% Elicera Therapeutics (OM:ELIC) 27.8% 97.2% Vow (OB:VOW) 12.9% 120.9% Pharma Mar (BME:PHM) 11.9% 39.8% CD Projekt (WSE:CDR) 29.7% 39.4% Bergen Carbon Solutions (OB:BCS) 12% 50.8% Truecaller (OM:TRUE B) 29.7% 24.8% XTPL (WSE:XTP) 27.9% 118% Elliptic Laboratories (OB:ELABS) 22.6% 89.9% Circus (XTRA:CA1) 26% 51.4% Click here to see the full list of 216 stocks from our Fast Growing European Companies With High Insider Ownership screener. Let's dive into some prime choices out of the screener. Simply Wall St Growth Rating: ★★★★☆☆ Overview: P/F Bakkafrost, along with its subsidiaries, is engaged in the production and sale of salmon products across North America, Western Europe, Eastern Europe, Asia, and other international markets, with a market cap of NOK33.54 billion. Operations: The company's revenue segments include Sales and Other at DKK10.21 billion, Farming Faroe Islands at DKK3.97 billion, Fishmeal, Oil and Feed at DKK2.73 billion, Farming Scotland at DKK1.84 billion, Services at DKK894.61 million, Freshwater Faroe Islands at DKK782.05 million, and Freshwater Scotland at DKK117.26 million. Insider Ownership: 13.3% Revenue Growth Forecast: 13.8% p.a. P/F Bakkafrost's earnings are projected to grow at 34.9% annually, outpacing the Norwegian market's growth rate of 8.3%. Despite a decline in profit margins from last year, analysts expect the stock price to rise by 21.9%, and it trades significantly below its estimated fair value. Recent financials show sales increased to DKK 7.48 billion, though net income decreased compared to the previous year, reflecting challenges in maintaining profitability amidst growth expectations. Click here and access our complete growth analysis report to understand the dynamics of P/F Bakkafrost. In light of our recent valuation report, it seems possible that P/F Bakkafrost is trading behind its estimated value. Simply Wall St Growth Rating: ★★★★★☆ Overview: CTT Systems AB (publ) designs, manufactures, and sells humidity control systems for aircraft in Sweden, Denmark, France, the United States, and internationally with a market cap of SEK2.91 billion. Operations: The company's revenue segment includes Aerospace & Defense, generating SEK302.30 million. Insider Ownership: 16.9% Revenue Growth Forecast: 19.5% p.a. CTT Systems is positioned for substantial growth, with earnings expected to grow significantly at 25.9% annually, outpacing the Swedish market's 9.5%. Despite trading at 46% below estimated fair value, its revenue growth forecast of 19.5% per year is slightly below the high-growth threshold but exceeds the Swedish market average. Recent orders for Anti-Condensation systems from a European airline signal robust demand, though net income has slightly declined compared to last year. Click to explore a detailed breakdown of our findings in CTT Systems' earnings growth report. Our valuation report unveils the possibility CTT Systems' shares may be trading at a discount. Simply Wall St Growth Rating: ★★★★★☆ Overview: Shoper SA offers Software as a Service solutions for e-commerce in Poland, with a market cap of PLN1.16 billion. Operations: The company's revenue is derived from its Solutions segment, generating PLN141.44 million, and Subscriptions, contributing PLN39.87 million. Insider Ownership: 23.6% Revenue Growth Forecast: 14.8% p.a. Shoper's earnings are projected to grow significantly at 26.56% annually, surpassing the Polish market's 14%. Despite trading at 23.5% below estimated fair value, its revenue growth of 14.8% per year lags behind the high-growth benchmark but exceeds local market expectations. Analysts agree on a potential stock price rise of 23.7%. A recent extraordinary shareholders meeting indicates active corporate governance, although no substantial insider trading activity was reported in the past three months. Delve into the full analysis future growth report here for a deeper understanding of Shoper. According our valuation report, there's an indication that Shoper's share price might be on the cheaper side. Access the full spectrum of 216 Fast Growing European Companies With High Insider Ownership by clicking on this link. Are these companies part of your investment strategy? Use Simply Wall St to consolidate your holdings into a portfolio and gain insights with our comprehensive analysis tools. Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include OB:BAKKA OM:CTT and WSE:SHO. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
